(Q44177995)

30 November 2017

title

Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice (English)

1 reference

30 November 2017

1 reference

14

1 reference

30 November 2017

10

Alain Tedgui

1 reference

30 November 2017

7

Ziad Mallat

1 reference

30 November 2017

Hélène Duez

1

1 reference

30 November 2017

Yu-Sheng Chao

2

1 reference

30 November 2017

Melba Hernandez

3

1 reference

30 November 2017

Gérard Torpier

4

1 reference

30 November 2017

Philippe Poulain

5

1 reference

30 November 2017

Steven Mundt

6

1 reference

30 November 2017

Elisabeth Teissier

8

1 reference

30 November 2017

Charlotte A Burton

9

1 reference

30 November 2017

Jean-Charles Fruchart

11

1 reference

30 November 2017

Catherine Fiévet

12

1 reference

30 November 2017

Sam D Wright

13

1 reference

30 November 2017

language of work or name

English

0 references

publication date

10 October 2002

1 reference

Journal of Biological Chemistry

30 November 2017

published in

1 reference

30 November 2017

volume

277

1 reference

30 November 2017

issue

50

1 reference

30 November 2017

page(s)

48051-48057

1 reference

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Regulation of lipid and lipoprotein metabolism by PPAR activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Peroxisome proliferator-activated receptors in inflammation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

HDL and arteriosclerosis: beyond reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

The role of PPARs in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206966200

21 January 2018

Identifiers

DOI

10.1074/JBC.M206966200

1 reference

30 November 2017

1 reference